162 related articles for article (PubMed ID: 29122635)
1. Inpatient Proton Pump Inhibitor Administration and Hospital-Acquired Clostridium difficile Infection: Evidence and Possible Mechanism.
Wombwell E; Chittum ME; Leeser KR
Am J Med; 2018 Mar; 131(3):244-249. PubMed ID: 29122635
[TBL] [Abstract][Full Text] [Related]
2. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
Gordon D; Young LR; Reddy S; Bergman C; Young JD
J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
[TBL] [Abstract][Full Text] [Related]
3. Hospital-acquired Clostridium difficile infection among patients with type 2 diabetes mellitus in acute medical wards.
Hassan SA; Rahman RA; Huda N; Wan Bebakar WM; Lee YY
J R Coll Physicians Edinb; 2013; 43(2):103-7. PubMed ID: 23734349
[TBL] [Abstract][Full Text] [Related]
4. Use of Proton Pump Inhibitors and Risk of Nosocomial Clostridium Difficile Infection in Hospitalized Elderly Adults.
Depoorter L; Verhaegen J; Joosten E
J Am Geriatr Soc; 2016 Mar; 64(3):667-9. PubMed ID: 27000353
[No Abstract] [Full Text] [Related]
5. Evolving Insights Into the Epidemiology and Control of Clostridium difficile in Hospitals.
Caroff DA; Yokoe DS; Klompas M
Clin Infect Dis; 2017 Oct; 65(7):1232-1238. PubMed ID: 28520953
[TBL] [Abstract][Full Text] [Related]
6. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.
Howell MD; Novack V; Grgurich P; Soulliard D; Novack L; Pencina M; Talmor D
Arch Intern Med; 2010 May; 170(9):784-90. PubMed ID: 20458086
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy.
King RN; Lager SL
Pharmacotherapy; 2011 Jul; 31(7):642-8. PubMed ID: 21923450
[TBL] [Abstract][Full Text] [Related]
8. Clostridium difficile infection and proton pump inhibitors.
Pohl JF
Curr Opin Pediatr; 2012 Oct; 24(5):627-31. PubMed ID: 22781139
[TBL] [Abstract][Full Text] [Related]
9. Severity and frequency of community-onset Clostridium difficile infection on an Australian tertiary referral hospital campus.
Clohessy P; Merif J; Post JJ
Int J Infect Dis; 2014 Dec; 29():152-5. PubMed ID: 25449250
[TBL] [Abstract][Full Text] [Related]
10. [Characteristics of Clostridium difficile infection in a high complexity hospital and report of the circulation of the NAP1/027 hypervirulent strain in Colombia].
Gualtero SM; Abril LA; Camelo N; Sanchez SD; Davila FA; Arias G; Silva E; Bustos IG; Josa DF; Torres IC; Zambrano LC; Pareja MJ
Biomedica; 2017 Dec; 37(4):466-472. PubMed ID: 29373767
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitors and diarrhoea related to Clostridium difficile infection in hospitalised patients: a case-control study.
Leonard AD; Ho KM; Flexman J
Intern Med J; 2012 May; 42(5):591-4. PubMed ID: 22616966
[TBL] [Abstract][Full Text] [Related]
12. Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection.
Brown K; Valenta K; Fisman D; Simor A; Daneman N
JAMA Intern Med; 2015 Apr; 175(4):626-33. PubMed ID: 25705994
[TBL] [Abstract][Full Text] [Related]
13. Clostridium difficile associated diarrhoea: An increased problem.
Urbina Soto L; García Ávila S; Córdoba Alonso AI; Roiz Mesones MP; Arnaiz García AM; Valero Díaz de Lamadrid MC
Med Clin (Barc); 2016 Dec; 147(12):543-546. PubMed ID: 27823794
[TBL] [Abstract][Full Text] [Related]
14. Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium difficile Infection.
McDonald EG; Milligan J; Frenette C; Lee TC
JAMA Intern Med; 2015 May; 175(5):784-91. PubMed ID: 25730198
[TBL] [Abstract][Full Text] [Related]
15. Implementation of Global Strategies to Prevent Hospital-Onset Clostridium difficile Infection: Targeting Proton Pump Inhibitors and Probiotics.
Lewis PO; Lundberg TS; Tharp JL; Runnels CW
Ann Pharmacother; 2017 Oct; 51(10):848-854. PubMed ID: 28821215
[TBL] [Abstract][Full Text] [Related]
16. Assessing the Risk of Hospital-Acquired Clostridium Difficile Infection With Proton Pump Inhibitor Use: A Meta-Analysis.
Arriola V; Tischendorf J; Musuuza J; Barker A; Rozelle JW; Safdar N
Infect Control Hosp Epidemiol; 2016 Dec; 37(12):1408-1417. PubMed ID: 27677811
[TBL] [Abstract][Full Text] [Related]
17. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.
Kurti Z; Lovasz BD; Mandel MD; Csima Z; Golovics PA; Csako BD; Mohas A; Gönczi L; Gecse KB; Kiss LS; Szathmari M; Lakatos PL
World J Gastroenterol; 2015 Jun; 21(21):6728-35. PubMed ID: 26074711
[TBL] [Abstract][Full Text] [Related]
18. Incidence of Clostridium difficile associated diarrhoea in a tertiary care hospital.
Kaneria MV; Paul S
J Assoc Physicians India; 2012 Nov; 60():26-8. PubMed ID: 23767199
[TBL] [Abstract][Full Text] [Related]
19. The burden of Clostridium difficile in surgical patients in the United States.
Zerey M; Paton BL; Lincourt AE; Gersin KS; Kercher KW; Heniford BT
Surg Infect (Larchmt); 2007 Dec; 8(6):557-66. PubMed ID: 18171114
[TBL] [Abstract][Full Text] [Related]
20. An analysis of risk factors of Clostridiumdifficile infection in patients hospitalized in the teaching hospital in 2008.
Dulny G; Zalewska M; Mlynarczyk G
Przegl Epidemiol; 2013; 67(3):445-50, 547-51. PubMed ID: 24340558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
